Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 7/20 | 0.48 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | AVPR1A | P37288 | 6/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CPT1A | P50416 | 1/20 | 0.41 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8563394 | 0.90 | NPC1 (0.50) | AVPR2MEN1KMT2AAVPR1AALDH1A1 | |
| SCHEMBL8557927 | 0.89 | AVPR2 (0.51) | AVPR2GPR27AVPR1A | |
| SCHEMBL8557610 | 0.89 | MAPT (0.52) | AVPR2KMT2AAVPR1APOLBALDH1A1 | |
| SCHEMBL8563496 | 0.88 | AVPR2 (0.56) | AVPR2MEN1KMT2AAVPR1A | |
| SCHEMBL8558117 | 0.86 | AVPR2 (0.47) | AVPR2MEN1KMT2AAVPR1APOLB | |
| SCHEMBL8563047 | 0.83 | AVPR1A (0.51) | KMT2AAVPR1A | |
| SCHEMBL8561396 | 0.82 | AVPR2 (0.42) | AVPR2AVPR1A | |
| SCHEMBL8560617 | 0.82 | AVPR1A (0.49) | AVPR2AVPR1A | |
| SCHEMBL8556903 | 0.82 | AVPR2 (0.53) | AVPR2MEN1KMT2AAVPR1APOLB | |
| SCHEMBL8562938 | 0.82 | AVPR2 (0.45) | AVPR2AVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0640592-B1 | N-acylated tricyclic azaheterorings useful as vasopressin antagonists | AMERICAN CYANAMID CO (US) | 1998-12-30 | — | — | EP | disclosed |